AstraZeneca logo

Senior Director, Competitive Intelligence, Oncology R&D

AstraZeneca

Gaithersburg, MD; Boston, MA; New York, NY; London, GB; Cambridge, GBHybridPosted 37 days ago$218,330 - $327,494/year
Full TimeDirector & AboveResearch & ScientistPharmaceutical
Original posting ↗

Summary

The Competitive Intelligence and Analysis team sits at the heart of developing commercial and clinical strategy and has an impact on decision-making at the highest levels. In this role, you will be a part of a high-achieving Strategy Team, with responsibility for ensuring the decisions we make with our pipeline assets best position us for return on investment and positive patient outcomes.

Job description

As a Senior Director, Competitive Intelligence, you will work with a team of specialists and own the delivery of competitive analysis, using your knowledge of the Oncology therapy area and external resources to shape future-proofed therapy area (TA) strategies. You will drive in-depth analysis of clinical and commercial data, generating and communicating critical insights on key issues to provide transparency and respectful challenge to key decision makers.

Essential Qualifications

  • Bachelor's degree and at least 3 years of experience working in research and/or with data, analysis and fact-based decision-making (equity research background is a definite asset)
  • A critical, innovative thinker with a background in oncology, clinical / research or investment analysis and the ability to communicate complex issues simply and clearly
  • Ability to think critically, creatively and to anticipate and solve problems, with excellent analysis and fact-based decision-making capabilities
  • Highly intellectually capable with agility and adaptability, motivated by working in a fast-paced field with clear societal impact
  • Experienced in leading cross-functional teams with ability to influence without authority to lead in a fast-paced, highly matrixed work environment
  • Resourceful, motivated, decisive and proactive; able to manage multiple priorities in a fast-growing organization

Preferred Qualifications

  • PhD in Life Sciences, MD or MBA
  • Background in management consulting, venture capital, private equity, or finance and deep experience with clinical data and analysis (financial models, industry trends)
  • Understanding of the Oncology TA with experience in the pharmaceutical industry or consulting contributing to strategic planning and portfolio decisions
  • In-depth understanding of clinical data, clinical trial design or regulatory frameworks

Requirements

  • Bachelor's degree
  • At least 3 years of experience working in research and/or with data, analysis and fact-based decision-making
  • Background in oncology, clinical / research or investment analysis
  • Ability to communicate complex issues simply and clearly
  • Ability to think critically, creatively and to anticipate and solve problems
  • Excellent analysis and fact-based decision-making capabilities
  • Agility and adaptability
  • Experienced in leading cross-functional teams
  • Ability to influence without authority
  • Resourceful, motivated, decisive and proactive
  • Able to manage multiple priorities

Benefits

  • Retirement programs
  • Paid time off
  • Health insurance
  • Dental insurance
  • Vision coverage
  • Short-term incentive bonuses
  • Equity-based awards

Company overview

AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.